Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine nasal spray plus thoracic paravertebral nerve block for sleep and pain in herpes zoster neuralgia
ChiCTR2500109200Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in postherpetic neuralgia (PHN) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Total Sleep Time. Started Sep 2025; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR2500109200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109200.